Envigo

Error creating thumbnail:

Envigo logo

Envigo was a global company that provided research models and services for the pharmaceutical and biotechnology industries, academic institutions, and government research centers. The company was known for its contributions to the life sciences sector, particularly in the development and supply of laboratory animals, including rodents, rabbits, and non-human primates, for use in basic research and non-clinical drug development studies. Envigo's services also encompassed a wide range of additional support for biomedical research, including contract breeding, genetic testing, and biosecurity programs.

History

The origins of Envigo trace back to the amalgamation of several smaller life sciences and research model companies. Over the years, through strategic acquisitions and mergers, Envigo expanded its portfolio of products and services to become a significant player in the life sciences research community. The company's growth was driven by the increasing demand for high-quality research models and the outsourcing of preclinical studies by pharmaceutical and biotechnology companies.

Services

Envigo offered a broad array of products and services designed to support the various stages of biomedical research and development. These included:

• Laboratory Animals: Envigo was renowned for its breeding and supply of a wide variety of research models, including genetically modified organisms (GMOs), disease-specific models, and standard laboratory animals like mice, rats, and rabbits.
• Genetic Testing Services: To ensure the integrity of research studies, Envigo provided comprehensive genetic testing services to verify the lineage and health status of their research models.
• Biosecurity and Animal Welfare: The company was committed to the highest standards of animal welfare and biosecurity, implementing rigorous protocols to ensure the health and well-being of the animals in their care.
• Contract Research Services: Envigo also offered contract research services, including toxicology studies, pharmacology research, and other non-clinical trial support.

Ethical Considerations

The use of animals in research is a subject of ethical debate. Envigo, like other companies in the field, operated under strict regulations designed to ensure the humane treatment of research animals. This included adherence to the principles of the 3Rs (Replacement, Reduction, and Refinement) to minimize animal use and suffering.

Acquisition and Legacy

In recent years, Envigo was acquired by or merged with other companies in the life sciences sector, further consolidating its position in the market and expanding its range of services. The legacy of Envigo continues to influence the field of biomedical research, with its contributions to the development of new medicines and therapies having a lasting impact on human and animal health.